Literature DB >> 9222972

Phosphoserine phosphatase deficiency in a patient with Williams syndrome.

J Jaeken1, M Detheux, J P Fryns, J F Collet, P Alliet, E Van Schaftingen.   

Abstract

Decreased serine levels were found in plasma and cerebrospinal fluid (CSF) of a boy with pre- and postnatal growth retardation, moderate psychomotor retardation, and facial dysmorphism suggestive of Williams syndrome. Fluorescence in situ hybridisation with an elastin gene probe indicated the presence of a submicroscopic 7q11.23 deletion, confirming this diagnosis. Further investigation showed that the phosphoserine phosphatase (EC 3.1.3.3.) activity in lymphoblasts and fibroblasts amounted to about 25% of normal values. Oral serine normalised the plasma and CSF levels of this amino acid and seemed to have some clinical effect. These data suggest that the elastin gene and the phosphoserine phosphatase gene might be closely linked. This seems to be the first report of phosphoserine phosphatase deficiency.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9222972      PMCID: PMC1051004          DOI: 10.1136/jmg.34.7.594

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  15 in total

1.  Supravalvular aortic stenosis.

Authors:  J C WILLIAMS; B G BARRATT-BOYES; J B LOWE
Journal:  Circulation       Date:  1961-12       Impact factor: 29.690

2.  The reactions of the phosphorylated pathway of L-serine biosynthesis: thermodynamic relationships in rabbit liver in vivo.

Authors:  K Lund; D K Merrill; R W Guynn
Journal:  Arch Biochem Biophys       Date:  1985-02-15       Impact factor: 4.013

3.  Phosphoserine phosphatase distribution in normal and neoplastic rat tissues.

Authors:  W E Knox; A Herzfeld; J Hudson
Journal:  Arch Biochem Biophys       Date:  1969-07       Impact factor: 4.013

4.  Enzymes of serine metabolism in normal and neoplastic rat tissues.

Authors:  K Snell
Journal:  Biochim Biophys Acta       Date:  1985-12-13

5.  Gene dosage studies regionally assign the phosphoserine phosphatase gene to 7p15.1 or 2.

Authors:  G Novelli; B Dallapiccola
Journal:  Ann Genet       Date:  1988

6.  Enzymes of serine metabolism in normal, developing and neoplastic rat tissues.

Authors:  K Snell
Journal:  Adv Enzyme Regul       Date:  1984

7.  Assignment of the human phosphoserine phosphatase gene (PSP) to the pter leads to q22 region of chromosome 7.

Authors:  G A Koch; R L Eddy; L L Haley; M G Byers; M McAvoy; T B Shows
Journal:  Cytogenet Cell Genet       Date:  1983

8.  The human phosphoserine phosphatase gene (PSP) is mapped to chromosome 7 by somatic cell genetic analysis.

Authors:  R S Sparkes; T Mohandas; M C Sparkes
Journal:  Cytogenet Cell Genet       Date:  1983

9.  Genetical and biochemical studies on human phosphoserine phosphatase.

Authors:  A M Moro-Furlani; V S Turner; D A Hopkinson
Journal:  Ann Hum Genet       Date:  1980-05       Impact factor: 1.670

10.  Natural history of Williams syndrome: physical characteristics.

Authors:  C A Morris; S A Demsey; C O Leonard; C Dilts; B L Blackburn
Journal:  J Pediatr       Date:  1988-08       Impact factor: 4.406

View more
  17 in total

1.  Mutations affecting the development of the peripheral nervous system in Drosophila: a molecular screen for novel proteins.

Authors:  S N Prokopenko; Y He; Y Lu; H J Bellen
Journal:  Genetics       Date:  2000-12       Impact factor: 4.562

2.  On the phenotypic spectrum of serine biosynthesis defects.

Authors:  Ayman W El-Hattab; Ranad Shaheen; Jozef Hertecant; Hassan I Galadari; Badi S Albaqawi; Amira Nabil; Fowzan S Alkuraya
Journal:  J Inherit Metab Dis       Date:  2016-03-10       Impact factor: 4.982

Review 3.  Treatment with amino acids in serine deficiency disorders.

Authors:  T J de Koning
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

4.  Phosphoserine aminotransferase deficiency: a novel disorder of the serine biosynthesis pathway.

Authors:  Claire E Hart; Valerie Race; Younes Achouri; Elsa Wiame; Mark Sharrard; Simon E Olpin; Jennifer Watkinson; James R Bonham; Jaak Jaeken; Gert Matthijs; Emile Van Schaftingen
Journal:  Am J Hum Genet       Date:  2007-03-30       Impact factor: 11.025

5.  Integrative genomics identifies 7p11.2 as a novel locus for fever and clinical stress response in humans.

Authors:  Jane F Ferguson; Nuala J Meyer; Liming Qu; Chenyi Xue; Yichuan Liu; Stephanie L DerOhannessian; Melanie Rushefski; Georgios K Paschos; Soonyew Tang; Eric E Schadt; Mingyao Li; Jason D Christie; Muredach P Reilly
Journal:  Hum Mol Genet       Date:  2014-11-20       Impact factor: 6.150

Review 6.  L-serine in disease and development.

Authors:  Tom J de Koning; Keith Snell; Marinus Duran; Ruud Berger; Bwee-Tien Poll-The; Robert Surtees
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

7.  Transcriptomic analysis identifies phosphatases as novel targets for adenotonsillar hypertrophy of pediatric obstructive sleep apnea.

Authors:  Abdelnaby Khalyfa; Sina A Gharib; Jinkwan Kim; Ehab Dayyat; Ayelet B Snow; Rakesh Bhattacharjee; Leila Kheirandish-Gozal; Julie L Goldman; David Gozal
Journal:  Am J Respir Crit Care Med       Date:  2010-01-21       Impact factor: 21.405

8.  Inactivation of the 3-phosphoglycerate dehydrogenase gene in mice: changes in gene expression and associated regulatory networks resulting from serine deficiency.

Authors:  Shigeki Furuya; Kazuyuki Yoshida; Yuriko Kawakami; Jyung Hoon Yang; Tomoko Sayano; Norihiro Azuma; Hideyuki Tanaka; Satoru Kuhara; Yoshio Hirabayashi
Journal:  Funct Integr Genomics       Date:  2008-01-29       Impact factor: 3.410

9.  An update on serine deficiency disorders.

Authors:  S N van der Crabben; N M Verhoeven-Duif; E H Brilstra; L Van Maldergem; T Coskun; E Rubio-Gozalbo; R Berger; T J de Koning
Journal:  J Inherit Metab Dis       Date:  2013-03-06       Impact factor: 4.982

10.  Influence of sex on gene expression in human corneal epithelial cells.

Authors:  Tomo Suzuki; Stephen M Richards; Shaohui Liu; Roderick V Jensen; David A Sullivan
Journal:  Mol Vis       Date:  2009-12-03       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.